Epstein-Barr Virus Reactivation in COVID-19 Long-Haul Syndrome: Etiology, Immune Dysfunction, and Genomic Vulnerability

John Murphy, CEO, COVID-19 Long-haul Foundation I. Abstract The persistence of symptoms following acute SARS-CoV-2 infection—commonly referred to as long COVID—has emerged as a global health crisis. Among the most…[...]

Read More

🧠 Neurovascular and Genomic Underpinnings of COVID-19 Brain Fog: A Multisystem Analysis of Etiology, Pathophysiology, and Therapeutic Targets

John Murphy, CEO, The COVID-19 Long-haul Foundation Abstract COVID-19 brain fog, a hallmark of post-acute sequelae of SARS-CoV-2 infection (PASC), represents a complex neurocognitive syndrome characterized by impaired memory, attention,…[...]

Read More

Influenza A (H1N1) and COVID-19 Pneumonias: An Evaluation in the Light of New Hematologic Indices

Yeşildağ M , Kocabas R, DOI https://doi.org/10.2147/JIR.S54538Objective:  Influenza A (H1N1) and COVID-19 viruses are two very different airway viral pneumonia agents that cause similar clinical manifestations and coinfections. The aim of this study…[...]

Read More